Exponent Welcomes Dr. John Doyle as Group Vice President for Health Sciences

Rhea-AI Summary

Exponent, Inc. (NASDAQ: EXPO) announced the appointment of John Doyle, Dr.P.H., as Group Vice President, Health Sciences on May 17, 2021. Dr. Doyle will lead the company's Health Sciences team, addressing environmental, occupational, medical, and public health challenges. CEO Dr. Catherine Corrigan highlighted Dr. Doyle's experience in healthcare research and the pharmaceutical sector, aiming to drive growth in life sciences. Dr. Doyle has authored over 200 research articles, primarily in oncology, and holds advanced degrees in Epidemiology from Columbia University.

Positive

• Appointment of John Doyle as Group Vice President, Health Sciences, expected to enhance Exponent's capabilities in the life sciences sector.
• Doyle's leadership aims to leverage Exponent’s multidisciplinary expertise to drive growth in pharmaceutical consulting.

Negative

• None.

MENLO PARK, Calif., May 17, 2021 (GLOBE NEWSWIRE) -- Exponent, Inc. (NASDAQ: EXPO) today announced the hiring of John Doyle, Dr.P.H., as Group Vice President, Health Sciences.

Dr. Doyle will lead the firm’s Health Sciences team, which applies deep interdisciplinary expertise to evaluate a broad range of environmental, occupational, medical, and public health issues that face the world.

“I am incredibly excited to welcome John to the Exponent team. He brings unique experience and perspective to Exponent, having founded, built and led premium healthcare research consultancies focused on the international biopharmaceutical sector, and also having served as a pharmaceutical industry executive focused on innovation,” said Dr. Catherine Corrigan, Chief Executive Officer and President. “John will be working closely with me, our Operating Committee, and other stakeholders to accelerate our growth in the life sciences sector, leveraging Exponent’s powerful multidisciplinary approach, data science expertise, and cross-industry reputation as a leader in the analysis of real-world product safety and performance,” continued Dr. Corrigan.

“Exponent has a long history of advising clients across industries as they leverage complex technologies and real-world evidence to improve human health and safety,” commented Dr. Doyle. “The firm is uniquely positioned with its world-class multidisciplinary expertise to advise the global pharmaceutical industry as it seeks to deliver breakthroughs beyond medicines, and to catalyze value-based healthcare centered on equitable and affordable access for patients. I look forward to engaging with the entire Exponent team, as we draw upon the intellectual rigor and data-driven analysis that are the hallmarks of the firm to deliver groundbreaking insights into human health.”

In addition to his deep strategic expertise, Dr. Doyle has authored over 200 abstracts and original research articles in a variety of therapeutic areas, with special concentration in oncology. He received Doctor and Master of Public Health degrees in Epidemiology from the Mailman School of Public Health at Columbia University, where he maintains an adjunct faculty position.

Exponent is an engineering and scientific consulting firm providing solutions to complex problems. Exponent’s inter-disciplinary organization of scientists, physicians, engineers, and business consultants draws from more than 90 technical disciplines to solve the most pressing and complicated challenges facing stakeholders today. The firm leverages over 50 years of experience in analyzing accidents and failures to advise clients as they innovate their technologically complex products and processes, ensure the safety and health of their users, and address the challenges of sustainability.

More information about Exponent can be found at https://www.exponent.com/.

Exponent may be reached at (888) 656-EXPO, info@exponent.com, or www.exponent.com. 

FAQ

Who is the new Group Vice President at Exponent?

John Doyle, Dr.P.H., has been appointed as the new Group Vice President, Health Sciences at Exponent.

What is John Doyle's background?

John Doyle has extensive experience in founding and leading healthcare research consultancies in the international biopharmaceutical sector.

How will John Doyle impact Exponent's business?

John Doyle is expected to accelerate growth in the life sciences sector by applying his expertise and improving service offerings.

What is Exponent's focus in Health Sciences?

Exponent's Health Sciences team evaluates environmental, occupational, medical, and public health issues using a multidisciplinary approach.

When was John Doyle appointed at Exponent?

John Doyle was appointed as Group Vice President, Health Sciences on May 17, 2021.